Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANDES: Short-Term Anticoagulation vs Antiplatelet Therapy Post-LAAC
NCT03568890Phase 4Active, not recruiting
- Start
- Sep 2018
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Draxaban in device-associated thrombosis. Started Sep 2018; status: active, not recruiting.
02
Drugs
Draxaban
03
Conditions
device-associated thrombosis
Beyond the preview
Go deeper on NCT03568890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03568890.